![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessA EUFOREA comment on a lost comorbidity of asthma
“Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Im...
-
Article
CRS/CRSwNP in 2050: a look into the future
-
Article
Open AccessMepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Although the psychometric properties of patient-reported outcome measures (e.g. the 22-item Sino-nasal Outcomes Test [SNOT-22]) in chronic rhinosinusitis with nasal polyps (CRSwNP) have been defined, these def...
-
Article
Open AccessCorrection to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
An amendment to this paper has been published and can be accessed via the original article.
-
Article
Open AccessBenefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been ...
-
Article
Open AccessPrecision Medicine in Chronic Rhinosinusitis with Nasal Polyps
Chronic rhinosinusitis is a disease with high prevalence, significant impact on health-related quality of life (HRQoL) and it is associated with substantial healthcare and productivity costs. We face an urgent...
-
Chapter
Chronic Rhinosinusitis with Polyposis: Diagnosis and Treatment
When patients with chronic rhinosinusitis with polyposis (CRSwNP) visit our clinic, a proper diagnosis and evaluation of relevant factors is our first step in the patient care. CRSwNP is suspected in patients ...
-
Article
Open AccessEuropean Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017)
On March 29, 2017, a European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases (CRD) was organized by the European Forum for Research and Education in Allergy and Airway Diseases. ...
-
Article
Open AccessCapsaicin for Rhinitis
Rhinitis is a multifactorial disease characterized by symptoms of sneezing, rhinorrhea, postnasal drip, and nasal congestion. Non-allergic rhinitis is characterized by rhinitis symptoms without systemic sensit...
-
Article
IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs
Transdifferentiation between group 1 and group 3 innate lymphoid cells (ILCs) has been observed in the gut. Spits and colleagues now show lung ILC2s are able to convert into ILC1s in an IL-12-dependent manner.
-
Article
Open AccessA common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doc...
-
Article
Complications of balloon packing in epistaxis
Although balloon packing appears to be efficient to control epistaxis, severe local complications can occur. We describe four patients with local lesions after balloon packing. Prolonged balloon packing can ca...
-
Article
Open AccessRhinosinusitis in morbidity registrations in Dutch General Practice: a retro-spective case-control study
There is only limited accurate data on the epidemiology of rhinosinusitis in primary care.
-
Article
Open AccessA new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
-
Article
Open AccessIvacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215N
-
Article
Open AccessBreaking nasal epithelial cell tolerance lipopolysaccharide exposure by CD16 mediated co-stimulation with human serum immunoglobulin G
-
Article
Open AccessAcute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity
-
Article
Open AccessPatient reported outcome measurements in chronic rhinosinusitis; assessing the correlation between RSOM-31 and VAS.
-
Article
Open AccessA new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
-
Article
Open AccessNew insights into the pathogenesis of non-allergic rhinitis